Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis

References

• MeuneCTouzéETrinquartLAllanoreYTrends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studiesRheumatology200948101309131319696061
   PubMed Web of Science ®Google Scholar
• KitasGDGabrielSECardiovascular disease in rheumatoid arthritis: state of the art and future perspectivesAnn Rheum Dis201170181421109513
   PubMed Web of Science ®Google Scholar
• Van DoornumSMcCollGJenkinsAGreenDJWicksIPScreening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular functionArthritis Rheum2003481728012528106
   PubMed Web of Science ®Google Scholar
• ForteLCimminoGLoffredoFC-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromesInt J Cardiol2011125171221794939
   PubMed Web of Science ®Google Scholar
• SolomonDHKremerJCurtisJRExplaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severityAnn Rheum Dis201069111920192520444756
   PubMed Web of Science ®Google Scholar
• SandooAVeldhuijzen van ZantenJJMetsiosGSCarrollDKitasGDVascular function and morphology in rheumatoid arthritis: a systematic reviewRheumatology (Oxford)201150112125213921926155
   PubMed Web of Science ®Google Scholar
• MathieuSPereiraBDubostJJLussonJRSoubrierMNo significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatmentRheumatology20125161107111122328565
   PubMed Web of Science ®Google Scholar
• ArnettFCEdworthySMBlochDAMcShaneDJFriesJFCooperNSThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum198831315243358796
   PubMed Web of Science ®Google Scholar
• WilkinsonIBFuchsSAJansenIMSprattJCMurrayGDCockcroftJRReproducibility of velocity and augmentation index measured by analysisJ Hypertens199816207920849886900
   PubMed Web of Science ®Google Scholar
• BoutouyriePVermeerschSJReference values for arterial stiffness’ collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: “establishing normal and reference values”European Heart Journal201031192338235020530030
   PubMed Web of Science ®Google Scholar
• LaurentSCockcroftJvan BortelLEuropean network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applicationsEuropean Heart Journal200627212588260517000623
   PubMed Web of Science ®Google Scholar
• DulaiRPerryMTwycross-LewisRMorrisseyDAtzeniFGreenwaldSThe effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature reviewSemin Arthritis Rheum20124211822475245
   PubMed Web of Science ®Google Scholar
• KumeKAmanoKYamadaSHattaKOhtaHKuwabaNTocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trialJ Rheum201138102169217121807781
   PubMed Web of Science ®Google Scholar
• ProtogerouADZampeliEFragiadakiKStamatelopoulosKPapamichaelCSfikakisPPA pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritisAtherosclerosis2011219273473621968316
   PubMed Web of Science ®Google Scholar
• Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumHingoraniADCasasJPThe interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisLancet201237998221214122422421340
   PubMed Web of Science ®Google Scholar
• Characteristics of tocilizumabEuropean Medicines Agency2009 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000955/WC500054890.pdfAccessed November 9, 2013
   Google Scholar
• BannwarthBRichezCClinical safety of tocilizumab in rheumatoid arthritisExpert Opin Drug Saf201110112313121121872
   PubMed Web of Science ®Google Scholar
• KawashiriSYKawakamiAYamasakiSEffects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritisRheumatol Int201131445145620024554
   PubMed Web of Science ®Google Scholar
• HanselBBruckertELipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapyAnn Endocrinol (Paris)2010714257263 French20416859
   PubMed Web of Science ®Google Scholar
• PopaCNeteaMGRadstakeTInfluence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritisAnn Rheum Dis200564230330515231512
   PubMed Web of Science ®Google Scholar
• DahlqvistSREngstrandSBerglinEJohnsonOConversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapyScand J Rheumatol200635210711116641043
   PubMed Web of Science ®Google Scholar
• VisMNurmohamedMTWolbinkGShort term effects of infliximab on the lipid profile in patients with rheumatoid arthritisJ Rheumatol200532225225515693084
   PubMed Web of Science ®Google Scholar
• AllanoreYKahanASellamJEkindjianOGBorderieDEffects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritisClin Chim Acta20063651–214314816176811
   PubMed Web of Science ®Google Scholar
• KiortsisDNMavridisAKFilippatosTDVasakosSNikasSNDrososAAEffects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitisJ Rheumatol200633592192316541480
   PubMed Web of Science ®Google Scholar
• SoubrierMJouanelPMathieuSEffects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritisJoint Bone Spine2008751222417888710
   PubMed Web of Science ®Google Scholar
• PayetSPereiraBSoubrierMMathieuSThe effects of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysisSemin Arthritis Rheum2012414e4e522154222
   PubMed Web of Science ®Google Scholar
• DaïenCIDunyYBarnetcheTDaurèsJPCombeBMorelJEffect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysisAnn Rheum Dis201271686286822267329
   PubMed Web of Science ®Google Scholar
• van SijlAMPetersMJKnolDLThe effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysisSemin Arthritis Rheum201141339340021665247
   PubMed Web of Science ®Google Scholar
• KerekesGSoltészPDérHEffects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritisClin Rheumatol200928670571019319624
   PubMed Web of Science ®Google Scholar
• SchimmelEKYaziciYIncreased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experienceClin Exp Rheumatol200927344645119604437
   PubMed Web of Science ®Google Scholar
• BarnabeCMartinBJGhaliWASystematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritisArthritis Care Res (Hoboken)201163452252920957658
   PubMed Web of Science ®Google Scholar